THE TAPE
Accumulated Context

Reading the Market Into Aug 28, 2026 · 3:31 PM

Aug 28, 2026 · 3:31 PM

Market Context — 2026-08-28 EOD Update (v50)

Warsh's hawkish Fed pivot remains the dominant driver, now confirmed and quantified. September rate-hike odds sit at ~60% (from 35%) per CME FedWatch after Warsh's Jackson Hole speech argued underlying inflation hasn't improved. Goolsbee explicitly endorsed Warsh's framing live on CNBC; Schmid separately called policy "too accommodative" and inflation "stubborn," citing core PCE at 3.3% and floating 25-50bps of further hikes. 2-year yield at 4.32-4.34%, bear-flattening. Gold (-1.7-2%), Bitcoin (~$78k, down from $80k), and risk-sentiment metals/crypto are the clearest casualties; equities more resilient. Rate-cut hopes for September are dead — this is now the top macro risk, full stop.

NVDA earnings de-risked fundamentals but didn't spark a durable rally — "treading water" thesis holds. Beat/raise, 6% premarket pop, Huang defused circular-financing (Burry) and open-vs-closed-model bear cases, memory bottleneck (71-72% margins now, recovery by FY28) fully validated by SK Hynix (shortage through 2030, no downturn signals), Micron, and Sandisk/Kioxia's $31B Japan buildout. But broader tape faded on Warsh, and MU/SNDK sold off Thursday/Friday on profit-taking, not fundamentals. Memory inflation is now visibly spreading to consumer hardware (HP margin hit, Apple's Klarna-backed leasing pivot) — a structural, multi-quarter theme.

Semiconductor tariff threat is now a persistent, un-resolved overhang alongside Fed policy. Reports of tariffs extending to servers/laptops/consoles hit AVGO (-1.5%), AMD (-1%) Friday; White House denies specifics but hasn't killed it. Combined with BofA's Vivek Arya thesis (SOX could fall another 10% near-term on rates/positioning despite cheap 20x valuation vs 70% EPS growth), this reinforces a market using any excuse (Marvell's ~8% post-beat drop, Cathie Wood's AMD trim) for profit-taking after huge 2026 run-ups. Marvell drop is Street-unanimous "overreaction," October analyst day the next catalyst; raised FY27/28 guidance ($12B/$18B) largely ignored.

Oil/Iran de-risking continues gradually: Iranian exports down 80%+ to ~260k bpd, Gulf allies backfilled to 60%+ of pre-war levels (Goldman), WTI $80-82. Structural risk premium (Hormuz, sanctions) persists but isn't currently market-moving.

Unchanged: Biotech (XBI +34% YTD) remains the hedge trade; Goldman's financials-heavy "shared favorites" basket (+29% YTD) still working; Canada tariffs (Sept 8 retaliation) and 2027 auto tariffs remain unresolved drags on GM/Ford/Toyota/Honda.